(3S,4S)-1-Cyclobutyl-4-([5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino)piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide

ID: ALA4757001

PubChem CID: 141678082

Max Phase: Preclinical

Molecular Formula: C27H28F2N6O3

Molecular Weight: 522.56

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@H]1CCN(C2CCC2)C[C@@H]1C(=O)NC1(c2ncccn2)CC1)c1cc(-c2ccc(F)cc2F)on1

Standard InChI:  InChI=1S/C27H28F2N6O3/c28-16-5-6-18(20(29)13-16)23-14-22(34-38-23)25(37)32-21-7-12-35(17-3-1-4-17)15-19(21)24(36)33-27(8-9-27)26-30-10-2-11-31-26/h2,5-6,10-11,13-14,17,19,21H,1,3-4,7-9,12,15H2,(H,32,37)(H,33,36)/t19-,21-/m0/s1

Standard InChI Key:  QKLGYSXKZLVSCF-FPOVZHCZSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   11.0692  -19.6580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6648  -20.3679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4818  -20.3632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9825  -16.6877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6929  -16.2839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4347  -16.6177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9855  -16.0141    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5817  -15.3036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7813  -15.4683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9165  -14.5605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7310  -14.4817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0683  -13.7382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5922  -13.0730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7750  -13.1560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4414  -13.8997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9286  -12.3282    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.6284  -13.9820    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.2776  -16.2744    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9770  -17.5049    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.2666  -17.9087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5630  -17.4927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8547  -17.8931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8450  -18.7106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5497  -19.1261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2642  -18.7241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9691  -19.1376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6796  -18.7340    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9633  -19.9548    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6624  -21.1855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9491  -21.5855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9430  -22.4019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6484  -22.8163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3613  -22.4083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3639  -21.5932    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1330  -19.1117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3491  -18.8914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1293  -19.6785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9164  -19.8983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 10  1  0
 13 16  1  0
 15 17  1  0
  4 18  2  0
  4 19  1  0
 20 19  1  6
 20 21  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  1
 26 27  2  0
 26 28  1  0
 28  2  1  0
  2 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 23 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4757001

    ---

Associated Targets(Human)

ACKR3 Tchem C-X-C chemokine receptor type 7 (1102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 522.56Molecular Weight (Monoisotopic): 522.2191AlogP: 3.19#Rotatable Bonds: 7
Polar Surface Area: 113.25Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.92CX Basic pKa: 8.63CX LogP: 2.34CX LogD: 1.08
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.49Np Likeness Score: -1.51

References

1. Richard-Bildstein S,Aissaoui H,Pothier J,Schäfer G,Gnerre C,Lindenberg E,Lehembre F,Pouzol L,Guerry P.  (2020)  Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239.,  63  (24): [PMID:33314938] [10.1021/acs.jmedchem.0c01588]

Source